Publications and Presentations - Opioid Agonist Therapy

Goal 2B. Implementing Opioid Agonist Therapy

Publications

Research Publications

• Ang-Lee K, Oreskovich MR, Saxon AJ, Jaffe C, Meredith C, Ellis M-LK., Malte CA, Knox PC. (2006). Single Dose of 24 Milligrams of Buprenorphine for Heroin Detoxification: an Open-label Study. Journal of Psychoactive Drugs; 38, 505-512.
• Davison J, Sweeney M, Bush KR, Davis T, Calsyn D, Reoux J, Sloan KL, Kivlahan D. (2006). Treatment Engagement Following Inpatient Opioid Detoxification. Journal of Addictive Diseases; 25, 27-35.
• Gordon AJ, Trafton J, Saxon AJ, Calabrese VS, Gifford AL, Goodman F, McNicholas L, Liberto J. (2007). Implementation of Buprenorphine in the Department of Veteran Affairs: Results of the first three years. Drug and Alcohol Dependence; 90, 292-296.
• Humphreys K, Trafton JA, Oliva EM. (2007). Does Following Research-derived Practice Guidelines Improve Opiate-dependent Patients' Outcomes Under Everyday Practice Conditions? Results of the Multisite Opiate Substitution Treatment Study. Journal of Substance Abuse Treatment. May 11; [Epub ahead of print].
• Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. (2007). Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction. Ann Intern Med. Jan 16; 146(2), 116-127.
• Trafton, JA, Humphreys K, Harris AH, Oliva E. (2007). Consistent Adherence to Guidelines Improves Opioid Dependent Patients' First Year Outcomes. Journal of Behavioral Health Services Research; 34, 260-271.
• Trafton JA, Tracy SW, Oliva EM, Humphreys K. (2007). Different Components of Opioid-Substitution Treatment Predict Outcomes of Patients with and without a Parent with Substance-use Problems. Journal of Studies on Alcohol and Drugs; 68, 165-172.

Non-Research Publications

• Gordon AJ. (2006). Buprenorphine: A Novel Medication In Novel Environments To Treat Opioid Dependence. Counterdetails: The Educational Difference. Dec:2-5, (2006).
• Gordon AJ, Sullivan LE, Alford DP, Arnsten J, Gourevitch MN, Kertesz SG, Kunins HV, Merril JO, Samet JH, Fiellin DA. (2007). Update In Addiction Medicine For The Generalist. Journal of General Internal Medicine; 22, 1190-1194.

Presentations

• Gordon AJ, McNicholas L, Dorsey D, Granda S., Salmon-Cox S., Andree TZ, Liberto J. Provider Outcomes Of VHA National Trainings To Enable Office-Based Treatment Of Opioid Dependence. Veterans Health Affairs' Transforming VHA Mental Health Care Conference, Washington, DC. July 2007.
• Gordon AJ, Trafton J, Saxon AJ, Calabrese VS, Gifford AL, Goodman F, McNicholas L, Liberto J. Implementation Of Buprenorphine In The VA: Results Of The First Three Years. Poster presentation at The College on Problems of Drug Dependence, Quebec City, Canada. June 2007.
• Kosten T. Addressing Depression In Opioid-Maintained Patients. Plenary session, presented at Safer Options in the Treatment of Opioid Dependence, Prague, Czech Republic. April 16-19, 2007.
• Kosten T. Management Of Substance Abuse: Alcohol And Prescription Opiates. Presented at Case Management Society of American, Denver, Colorado. June 19-22, 2007.
• Kosten T. Opioid Addiction And Pain: Common Features, Receptors And Treatment. Chair, Session 6. The European Association of Addiction Therapy Conference, Vienna, Austria. September 10-12, 2007.
• Saxon A, Storti S, Boverman J, Dickinson B. Understanding and Utilizing Buprenorphine in the Treatment of Opioid Addiction Blending Addiction Science and Practice: Bridges to the Future, National Institute on Drug Abuse, Seattle, WA. October 16, 2006.